Published in Kidney Int on March 09, 2011
Adverse cardiac remodelling in spontaneously hypertensive rats: acceleration by high aerobic exercise intensity. J Physiol (2012) 1.29
Patient trust in physicians and adoption of lifestyle behaviors to control high blood pressure. Patient Educ Couns (2012) 0.90
Prehypertension: Underlying pathology and therapeutic options. World J Cardiol (2014) 0.80
Recognition and Management of Resistant Hypertension. Clin J Am Soc Nephrol (2016) 0.80
The association of genetic variations with sensitivity of blood pressure to dietary salt: A narrative literature review. ARYA Atheroscler (2014) 0.79
Treatment of prehypertension: lifestyle and/or medication. Vasc Health Risk Manag (2012) 0.76
Efficacy of a church-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members: a randomized controlled trial in Pretoria, South Africa. BMC Public Health (2014) 0.76
Effects of Lifestyle Modification on Telomerase Gene Expression in Hypertensive Patients: A Pilot Trial of Stress Reduction and Health Education Programs in African Americans. PLoS One (2015) 0.76
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA (2003) 13.82
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Human hypertension caused by mutations in WNK kinases. Science (2001) 8.71
Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89
Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. BMJ (1988) 6.59
Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med (2002) 5.92
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (2006) 5.59
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med (2010) 5.14
End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09
Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med (1993) 4.59
Relative contributions of dietary sodium sources. J Am Coll Nutr (1991) 4.24
WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest (2003) 3.67
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27
Hypertension awareness, treatment, and control--continued disparities in adults: United States, 2005-2006. NCHS Data Brief (2008) 3.04
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension (2000) 3.01
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med (2005) 2.90
Failure of exercise to reduce blood pressure in patients with mild hypertension. Results of a randomized controlled trial. JAMA (1991) 2.88
Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med (2010) 2.58
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension (2004) 2.36
The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group. Arch Intern Med (1990) 2.31
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev (2010) 2.22
Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture. Circulation (1975) 2.17
Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med (2002) 2.13
Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). Hypertension (2002) 2.08
Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens (2003) 1.96
Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol (1999) 1.95
Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A (2006) 1.93
Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials. Hypertension (2000) 1.93
Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83
Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial. Hypertension (1985) 1.81
Pressor effect of alcohol in hypertension. Lancet (1984) 1.79
WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci U S A (2005) 1.76
Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens (2006) 1.74
Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension (1999) 1.74
The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest (2007) 1.70
Increased blood pressure during potassium depletion in normotensive men. N Engl J Med (1989) 1.69
Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. JAMA (1990) 1.63
Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension (2008) 1.60
Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) (1983) 1.54
The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med (1990) 1.54
The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens (2002) 1.54
Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med (1998) 1.49
Blood pressure in four remote populations in the INTERSALT Study. Hypertension (1989) 1.48
Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet (1984) 1.48
Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension (1986) 1.45
Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med (1985) 1.43
Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension (2005) 1.41
Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr (1987) 1.30
Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev (2006) 1.29
Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol (2009) 1.28
Blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA (1977) 1.27
Effectiveness of advice to reduce alcohol consumption in hypertensive patients. Hypertension (1992) 1.23
Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. Hypertension (1993) 1.22
Lifestyle modification and blood pressure control: is the glass half full or half empty? JAMA (2003) 1.20
Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. BMJ (1990) 1.20
Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action. Lancet (1981) 1.17
The aftereffects of dynamic exercise on ambulatory blood pressure. Med Sci Sports Exerc (2001) 1.11
Effects of a short-term circuit weight training program on glycaemic control in NIDDM. Diabetes Res Clin Pract (1998) 1.11
Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients. J Hypertens (1992) 1.09
A prospective study of nutritional factors and hypertension among US women. Circulation (1989) 1.08
Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial. Arch Intern Med (1996) 1.07
Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J Am Soc Nephrol (1992) 1.06
Sodium restriction and potassium supplementation in young people with mildly elevated blood pressure. J Hypertens (1987) 1.06
Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension (1998) 1.06
Australian National Health and Medical Research Council dietary salt study in mild hypertension. J Hypertens Suppl (1986) 1.05
Randomised double-blind cross-over trial of potassium on blood-pressure in normal subjects. Lancet (1982) 1.02
Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) (1985) 1.01
The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens (1993) 0.99
Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98
Effect of reduced alcohol consumption on blood pressure in untreated hypertensive men. Hypertension (1993) 0.96
Effect of exercise training on blood pressure in 70- to 79-yr-old men and women. Med Sci Sports Exerc (1991) 0.95
Potassium supplementation in blacks with mild to moderate essential hypertension. J Hypertens (1986) 0.93
Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. Hypertension (2005) 0.93
Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension (1987) 0.92
Physiological response to circuit weight training in borderline hypertensive subjects. Med Sci Sports Exerc (1987) 0.92
Effect of regular exercise on 24-hour arterial pressure in older hypertensive humans. Hypertension (1991) 0.91
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.90
Controlled trial of long term oral potassium supplements in patients with mild hypertension. Br Med J (Clin Res Ed) (1987) 0.90
Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol (2007) 0.89
Influence of pattern of alcohol intake on blood pressure in regular drinkers: a controlled trial. J Hypertens (1998) 0.89
Effect of regular alcohol use on blood pressure control in treated hypertensive subjects: a controlled study. Clin Exp Pharmacol Physiol (1986) 0.88
Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men. Hypertension (1992) 0.88
Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens (1991) 0.87
Blood pressure and electrolyte excretion in the Yanomamo Indians, an isolated population. J Hum Hypertens (1989) 0.86
Use of home blood pressure monitoring and exercise, diet and medication compliance in Japan. Clin Exp Hypertens (2010) 0.86
Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group. J Epidemiol Community Health (1995) 0.86
NaCl-induced renal vasoconstriction in salt-sensitive African Americans: antipressor and hemodynamic effects of potassium bicarbonate. Hypertension (1999) 0.86
Long-term magnesium supplementation in essential hypertension. Cardiology (1992) 0.85
Oral magnesium supplementation in patients with essential hypertension. Hypertension (1989) 0.85
Effects of potassium on sodium balance, renin, noradrenaline and arterial pressure. J Hypertens (1985) 0.85
Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med (2013) 7.29
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol (2006) 1.98
What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol (2007) 1.60
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53
Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: the COBRA trial. J Am Coll Cardiol (2012) 1.43
Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol (2012) 1.42
Rhabdomyolysis: a review, with emphasis on the pediatric population. Pediatr Nephrol (2010) 1.08
Unfractionated heparin for hemodialysis: still the best option. Semin Dial (2010) 1.07
Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences. Clin J Am Soc Nephrol (2011) 1.06
Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents? Semin Dial (2008) 1.02
Hereditary disorders of renal phosphate wasting. Nat Rev Nephrol (2010) 0.98
Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention. Am J Cardiol (2011) 0.96
Hereditary etiologies of hypomagnesemia. Nat Clin Pract Nephrol (2008) 0.94
Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality. Am J Cardiol (2008) 0.89
Heparin-induced thrombocytopenia: a renal perspective. Nat Rev Nephrol (2009) 0.88
Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease. Semin Dial (2003) 0.87
Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney disease. Semin Dial (2008) 0.84
Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection. Nephrology (Carlton) (2005) 0.83
Vascular access surveillance: evaluation of combining dynamic venous pressure and vascular access blood flow measurements. Am J Nephrol (2003) 0.83
Association of urinary sodium-to-potassium ratio with obesity in a multiethnic cohort. Am J Clin Nutr (2014) 0.81
Spondylodiscitis in a patient on chronic hemodialysis. Nat Rev Nephrol (2011) 0.81
Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence? Clin J Am Soc Nephrol (2012) 0.80
Imaging patients with kidney disease: how do we approach contrast-related toxicity? Am J Med Sci (2011) 0.80
Primary care approach to proteinuria. J Am Board Fam Med (2008) 0.79
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders. Nephrology (Carlton) (2006) 0.78
Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion? Int Urol Nephrol (2010) 0.77
Gadolinium and nephrogenic systemic fibrosis: have we overreacted? Semin Dial (2011) 0.76
Anticoagulation and continuous renal replacement therapy. Semin Dial (2006) 0.75
Risk factors: filling in the gap. Nat Rev Nephrol (2012) 0.75
Hungry bone syndrome. Curr Opin Nephrol Hypertens (2017) 0.75
Dietary phosphate: what do we know about its toxicity. J Nephrol (2013) 0.75
Are calcium-based phosphate binders ever preferable in dialysis patients? Semin Dial (2014) 0.75
Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation? Semin Dial (2011) 0.75